Cargando…
PEG-PEI/siROCK2 inhibits Aβ(42)-induced microglial inflammation via NLRP3/caspase 1 pathway
OBJECTIVES: There is an urgent need to develop therapeutic strategies to improve the treatment outcome of Alzheimer’s disease. The treatment strategy of gene therapy mediated by nanocarrier systems brings new hope for the treatment of Alzheimer’s disease. ROCK2 is involved in various pathological pr...
Autores principales: | Liu, Yunyun, Zhang, Han, Peng, Anping, Cai, Xiaodong, Wang, YuZhou, Tang, Ke, Wu, Xiuqin, Liang, Yanran, Wang, Limin, Li, Zhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719500/ https://www.ncbi.nlm.nih.gov/pubmed/34874326 http://dx.doi.org/10.1097/WNR.0000000000001752 |
Ejemplares similares
-
Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma
por: Höbel, Sabrina, et al.
Publicado: (2011) -
Lipo-PEG-PEI complex as an intracellular transporter for protein therapeutics
por: Lin, Yu-Ling, et al.
Publicado: (2019) -
Fluorinated PEG-PEI Coated Magnetic Nanoparticles for siRNA Delivery and CXCR4 Knockdown
por: Cao, Yixiang, et al.
Publicado: (2022) -
ATPase Inhibitory Factor 1 Is Critical for Regulating Sevoflurane-Induced Microglial Inflammatory Responses and Caspase-3 Activation
por: Xu, Yaru, et al.
Publicado: (2021) -
Antiproliferative activity of CD44 siRNA-PEI-PEG nanoparticles in glioblastoma: involvement of AKT signaling
por: Mahinfar, Parvaneh, et al.
Publicado: (2021)